Increasing intravenous glucose load in the presence of normoglycemia: Effect on outcome and metabolism in critically ill rabbits

Critical Care Medicine

Volumn 38, Issue 2, 2010, Pages 602-611

  Derde, Sarah ^a   Vanhorebeek, Ilse ^a   Ververs, Eric Jan ^a   Vanhees, Ine ^a   Darras, Veerle M ^a   Van Herck, Erik ^a   Larsson, Lars ^b   Van Den Berghe, Greet ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Critical illness; Hyperglycemia; Insulin; Intravenous nutrition; Muscle catabolism

Indexed keywords

CALPAIN 1; CATHEPSIN L; GLUCOSE; INSULIN; MESSENGER RNA; SOMATOMEDIN C; THYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; DIAPHRAGM; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; HEART MUSCLE; HYPERGLYCEMIA; INTRAVENOUS FEEDING; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; MORTALITY; NONHUMAN; PARENTERAL NUTRITION; PRIORITY JOURNAL; RABBIT; WEIGHT REDUCTION;

EID: 74949108552     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181c03f65     Document Type: Article

References (60)

1. Debaveye Y, Van den Berghe G: Risks and benefits of nutritional support during critical illness. Annu Rev Nutr 2006; 26:513-538
2. Streat SJ, Beddoe AH, Hill GL: Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. J Trauma 1987; 27:262-266
3. Vanhorebeek I, Van den Berghe G: Hormonal and metabolic strategies to attenuate catab-olism in critically ill patients. Curr Opin Pharmacol 2004; 4:621-628
4. Jackman RW, Kandarian SC: The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 2004; 287:C834-C843
5. Voisin L, Breuille D, Combaret L, et al: Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca2+-activated, and ubiquitin-protea-some proteolytic pathways. J Clin Invest 1996; 97:1610-1617
6. Mansoor O, Beaufrere B, Boirie Y, et al: Increased mRNA levels for components of the lysosomal, Ca2 +-activated, and ATP-ubiq-uitin-dependent proteolytic pathways in skeletal muscle from head trauma patients. Proc Natl Acad Sci USA 1996; 93:2714-2718
7. Lecker SH: Ubiquitin-protein ligases in muscle wasting: Multiple parallel pathways? Curr Opin Clin Nutr Metab Care 2003; 6:271-275
8. Klaude M, Fredriksson K, Tjader I, et al: Proteasome proteolytic activity in skeletal muscle is increased in patients with sepsis. Clin Sci (Lond) 2007; 112:499-506
9. Smith IJ, Lecker SH, Hasselgren PO: Calpain activity and muscle wasting in sepsis. Am J Physiol Endocrinol Metab 2008; 295: E762-E771
10. Bechet D, Tassa A, Taillandier D, et al: Lysosomal proteolysis in skeletal muscle. Int J Biochem Cell Biol 2005; 37:2098-2114
11. Flakoll PJ, Hill JO, Abumrad NN: Acute hyperglycemia enhances proteolysis in normal man. Am J Physiol 1993; 265:E715-E721
12. Mizock BA: Alterations in carbohydrate metabolism during stress: A review of the literature. Am J Med 1995; 98:75-84
13. Van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367
14. Van den Berghe G, Wilmer A, Hermans G, et al: Intensive insulin therapy in the medical ICU. NEngl J Med 2006; 354:449-461
15. Vlasselaers D, Milants I, Desmet L, et al: Intensive insulin therapy for patients in pae-diatric intensive care: A prospective, randomised controlled study. Lancet 2009; 373: 547-556
16. Inzucchi SE, Siegel MD: Glucose control in the ICU-How tight is too tight? N Engl J Med 2009; 360:1346-1349
17. Van den Berghe G, Mesotten D, Vanhorebeek I: Intensive insulin therapy in the intensive care unit. CMAJ 2009; 180:799-800
18. Vanhorebeek I, Langouche L, Van den Berghe G: Tight blood glucose control with insulin in the ICU: Facts and controversies. Chest 2007; 132:268-278
19. Weekers F, Van Herck E, Coopmans W, et al: A novel in vivo rabbit model of hypercata-bolic critical illness reveals a biphasic neuroendocrine stress response. Endocrinology 2002; 143:764-774
20. Weekers F, Giulietti AP, Michalaki M, et al: Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology 2003; 144:5329-5338
21. Ellger B, Debaveye Y, Vanhorebeek I, et al: Survival benefits of intensive insulin therapy in critical illness: Impact of maintaining nor-moglycemia versus glycemia-independent actions of insulin. Diabetes 2006; 55: 1096-1105
22. Janes RG, Osburn JO: The analysis of glucose measurements by computer simulation. J Physiol 1965; 181:59-67
23. Hu RH, Yu YM, Costa D, et al: A rabbit model for metabolic studies after burn injury. J Surg Res 1998; 75:153-160
24. Wilmore DW: Nutrition and metabolism following thermal injury. Clin Plast Surg 1974; 1:603-619
25. Van der Geyten S, Van den Eynde I, Segers IB, et al: Differential expression of iodothy-ronine deiodinases in chicken tissues during the last week of embryonic development. Gen Comp Endocrinol 2002; 128:65-73
26. Norman H, Nordquist J, Andersson P, et al: Impact of post-synaptic block of neuromus-cular transmission, muscle unloading and mechanical ventilation on skeletal muscle protein and mRNA expression. Pflugers Arch 2006; 453:53-66
27. Wray CJ, Mammen JM, Hasselgren PO: Cat-abolic response to stress and potential benefits of nutrition support. Nutrition 2002; 18: 971-977
28. Vanhorebeek I, Ellger B, De Vos R, et al: Tissue-specific glucose toxicity induces mi-tochondrial damage in a burn injury model of critical illness. Crit Care Med 2009; 37: 1355-1364
29. Van den Berghe G, Schetz M, Vlasselaers D, et al: Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? J Clin Endocrinol Metab 2009; 94:3163-3170
30. Pittas AG, Siegel RD, Lau J: Insulin therapy and in-hospital mortality in critically ill patients: Systematic review and meta-analysis of randomized controlled trials. JPEN J Par-enter Enteral Nutr 2006; 30:164-172
31. Krinsley JS: Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004; 79:992-1000
32. Griesdale DE, de Souza RJ, van Dam RM, et al: Intensive insulin therapy and mortality among critically ill patients: A meta-analysis including NICE-SUGAR study data. CMAJ 2009; 180:821-827
33. Finfer S, Chittock DR, Su SY, et al: Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283-1297
34. Heidegger CP, Darmon P, Pichard C: Enteral vs. parenteral nutrition for the critically ill patient: A combined support should be preferred. Curr Opin Crit Care 2008; 14: 408-414
35. Fang CH, Tiao G, James H, et al: Burn injury stimulates multiple proteolytic pathways in skeletal muscle, including the ubiquitin-energy- dependent pathway. J Am Coll Surg 1995; 180:161-170
36. Helliwell TR, Wilkinson A, Griffiths RD, et al: Muscle fibre atrophy in critically ill patients is associated with the loss of myosin filaments and the presence of lysosomal enzymes and ubiquitin. Neuropathol Appl Neu-robiol 1998; 24:507-517
37. Tiao G, Hobler S, Wang JJ, et al: Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. J Clin Invest 1997; 99:163-168
38. Wray CJ, Mammen JM, Hershko DD, et al: Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle. Int J Biochem Cell Biol 2003; 35:698-705
39. Tiao G, Fagan JM, Samuels N, et al: Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle. J Clin Invest 1994; 94:2255-2264
40. Biolo G, Bosutti A, Iscra F, et al: Contribution of the ubiquitin-proteasome pathway to overall muscle proteolysis in hypercatabolic patients. Metabolism 2000; 49:689-691
41. Williams AB, Decourten-Meyers GM, Fischer JE, et al: Sepsis stimulates release of myo-filaments in skeletal muscle by a calcium-dependent mechanism. FASEB J 1999; 13: 1435-1443
42. Fareed MU, Evenson AR, Wei W, et al: Treatment of rats with calpain inhibitors prevents sepsis-induced muscle proteolysis independent of atrogin-1/MAFbx and MuRF1 expression. Am J Physiol Regul Integr Comp Physiol 2006; 290:R1589-R1597
43. Bailey P, Thomsen GE, Spuhler VJ, et al: Early activity is feasible and safe in respiratory failure patients. Crit Care Med 2007; 35:139-145
44. Levine S, Nguyen T, Taylor N, et al: Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med 2008; 358:1327-1335
45. Agus MS, Javid PJ, Ryan DP, et al: Intravenous insulin decreases protein breakdown in infants on extracorporeal membrane oxygen-ation. J Pediatr Surg 2004; 39:839-844
46. Solomon V, Madihally S, Yarmush M, et al: Insulin suppresses the increased activities of lysosomal cathepsins and ubiquitin conjugation system in burn-injured rats. J Surg Res 2000; 93:120-126
47. Gore DC, Chinkes DL, Hart DW, et al: Hy-perglycemia exacerbates muscle protein ca-tabolism in burn-injured patients. Crit Care Med 2002; 30:2438-2442
48. Vanhorebeek I, De Vos R, Mesotten D, et al: Protection of hepatocyte mitochondrial ul-trastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 2005; 365:53-59
49. Langouche L, Vander Perre S, Wouters PJ, et al: Effect of intensive insulin therapy on insulin sensitivity in the critically ill. J Clin Endocrinol Metab 2007; 92:3890-3897 (Pubitemid 47607638)
50. Van den Berghe G, Wouters P, Weekers F, et al: Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thy-rotropin-releasing hormone in patients with protracted critical illness. J Clin Endocrinol Metab 1999; 84:1311-1323
51. Sacheck JM, Ohtsuka A, McLary SC, et al: IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. Am J Physiol Endocrinol Metab 2004; 287:E591-E601
52. Frost RA, Nystrom GJ, Jefferson LS, et al: Hormone, cytokine, and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle. Am J Physiol Endocrinol Metab 2007; 292:E501-E512
53. Wartofsky L, Burman KD: Alterations in thyroid function in patients with systemic illness: The 'euthyroid sick syndrome.' Endocr Rev 1982; 3:164-217
54. Peeters RP, Wouters PJ, van Toor H, et al: Serum 3,3',5'-triiodothyronine (rT3) and 3,5,3'-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. J Clin Endocrinol Metab 2005; 90: 4559-4565
55. Peeters RP, Van der Geyten S, Wouters PJ, et al: Tissue thyroid hormone levels in critical illness. J Clin Endocrinol Metab 2005; 90: 6498-6507
56. Hasselgren PO, Pedersen P, Sax HC, et al: Methods for studying protein synthesis and degradation in liver and skeletal muscle. J Surg Res 1988; 45:389-415
57. Lang CH, Huber D, Frost RA: Burn-induced increase in atrogin-1 and MuRF-1 in skeletal muscle is glucocorticoid independent but downregulated by IGF-I. Am J Physiol Regul Integr Comp Physiol 2007; 292:R328-R336
58. Lazar HL, Chipkin SR, Fitzgerald CA, et al: Tight glycemic control in diabetic coronary artery bypass graft patients improves periop-erative outcomes and decreases recurrent ischemic events. Circulation 2004; 109: 1497-1502
59. Wang P, Lloyd SG, Chatham JC: Impact of high glucose/high insulin and dichloroac-etate treatment on carbohydrate oxidation and functional recovery after low-flow ischemia and reperfusion in the isolated perfused rat heart. Circulation 2005; 111:2066-2072
60. L'Her E, Sebert P: A global approach to energy metabolism in an experimental model of sepsis. Am J Respir Crit Care Med 2001; 164:1444-1447